This is a national registry study to determine the serumal biomarkers for prognosis of adverse events in patients undergoing coronary artery bypass grafting.
Study Type
OBSERVATIONAL
Enrollment
2,000
A type of operation for coranary heart disease patients.
Beijing Anzhen Hospital
Beijing, China
RECRUITINGAll-cause death and cardiac death
Time frame: These data is collected during follow-up visit at in-hospital/1 year after discharge
Major adverse cardiac events (MACE)
A composite of death, myocardial infarction, stroke, heart failure, ventricular arrhythmia
Time frame: These data is collected during follow-up visit at in-hospital/1 year after discharge
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.